Showing results (211-220 of 725) with videos related to
Sort By:
Pageof 73
British Journal of Clinical Pharmacology|October 1, 1989
Atrial natriuretic peptide and urinary prostaglandins in manD Benzoni, J Geoffroy, B Waeber, et al.Journal of Cardiovascular Pharmacology|January 1, 1987
Acute antihypertensive effect of angiotensin converting enzyme inhibition and calcium entry blockadeH R Brunner, J Nussberger, J Bidiville, et al.Life Sciences|December 7, 1987
Markedly reduced blood pressure responsiveness in endotoxemic rats; reversal by neuropeptide YD Evéquoz, B Waeber, R Corder, et al.Clinical and Experimental Pharmacology & Physiology|February 1, 1994
Mechanisms of the pressor response to intravenous thyrotropin-releasing hormone in the ratD Evequoz, M Burnier, M Niederberger, et al.Journal of Cardiovascular Pharmacology|December 1, 1994
Neuropeptide Y infusion decreases plasma renin activity in postmyocardial infarction ratsR Zelis, J Nussberger, B Clemson, et al.Experientia|October 15, 1994
Differential vascular effects of neuropeptide Y(NPY) selective receptor agonistsD Evéquoz, E Grouzmann, A G Beck-Sickinger, et al.Schweizerische Medizinische Wochenschrift|December 31, 1983
[Treatment of hypertensive crisis with captopril]J Biollaz, B Waeber, G A Turini, et al.European Journal of Pharmacology|June 17, 1986
The hemodynamic response of conscious normotensive rats to atriopeptin III: Lack of a role of the parasympathetic nervous systemB Waeber, G R Matsueda, J F Aubert, et al.American Journal of Hypertension|May 1, 1991
In vitro effects of DuP 753, a nonpeptide angiotensin II receptor antagonist, on human platelets and rat vascular smooth muscle cellsM Burnier, G Centeno, E Grouzmann, et al.Hypertension (Dallas, Tex. : 1979)|February 1, 1988
Individual responses to converting enzyme inhibitors and calcium antagonistsJ Bidiville, J Nussberger, G Waeber, et al.Pageof 73